N. Wong

发表

A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data.

M. Rattray, J. Sung, T. Poon, 2006, Gastroenterology.

A virome-wide clonal integration analysis platform for discovering cancer viral etiology

Winnie S. Liang, W. Liang, N. Wong, 2019, Genome research.

Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer

Chang Yu, Huanming Yang, Jun Yu, 2014, Gut.

Viral-human chimeric transcript predisposes risk to liver cancer development and progression.

H. Chan, N. Wong, P. Lai, 2014, Cancer cell.

Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma

J. Squire, N. Wong, P. Lai, 2006, Modern Pathology.

Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.

W. Lau, N. Wong, Y. Lo, 1999, Cancer research.

Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach.

N. Wong, W. Chan, A. Chan, 1998, The American journal of pathology.

Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.

C. Niu, N. Wong, P. Johnson, 1999, Cancer genetics and cytogenetics.

Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes.

S. Tsao, N. Wong, Y. Wong, 2002, Biochimica et biophysica acta.

Nasopharyngeal carcinoma cell line (C666‐1) consistently harbouring Epstein‐Barr virus

S. Cheung, N. Wong, S. Cheung, 1999, International journal of cancer.

O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.

Jun Yu, X. Zhang, N. Wong, 2017, Journal of hepatology.

Novel identification of zyxin upregulations in the motile phenotype of hepatocellular carcinoma

N. Wong, P. Johnson, P. Lai, 2006, Modern Pathology.

Size distributions of maternal and fetal DNA in maternal plasma.

A. Hui, N. Wong, K. C. Chan, 2004, Clinical chemistry.

Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.

W. Lau, N. Wong, Y. Lo, 1999, Cancer research.

High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma

W. Yeo, N. Wong, P. B. Lai, 2005, Liver international : official journal of the International Association for the Study of the Liver.

RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma.

J. Sung, H. Chan, N. Wong, 2007, Cancer letters.

Investigation of the genomic representation of plasma DNA in pregnant women by comparative genomic hybridization analysis: a feasibility study.

A. Hui, N. Wong, K. C. Chan, 2005, Clinical chemistry.

Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target

Jun Yu, J. Sung, N. Wong, 2018, Science Translational Medicine.

Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma.

N. Wong, K. Lai, T. Chan, 2013, Journal of hepatology.

Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.

J. Sung, W. Leung, N. Wong, 2003, International journal of oncology.

Carboxyl-Terminal Truncated HBx Regulates a Distinct MicroRNA Transcription Program in Hepatocellular Carcinoma Development

Jun Yu, A. Cheng, V. Wong, 2011, PloS one.

Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer

Jun Yu, A. Cheng, N. Wong, 2012, PloS one.

Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.

N. Wong, P. Lai, K. Man, 2019, Gastroenterology.

Personalized treatment for hepatocellular carcinoma: Current status and future perspectives

N. Wong, W. Lam, S. Chan, 2022, Journal of gastroenterology and hepatology.

AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis

Jun Yu, Feng Wu, N. Wong, 2020, Oncogene.

APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target

Jun Yu, M. Go, N. Wong, 2019, Theranostics.

Yin Yang 1‐mediated epigenetic silencing of tumour‐suppressive microRNAs activates nuclear factor‐κB in hepatocellular carcinoma

Jun Yu, W. Wu, A. Cheng, 2016, The Journal of pathology.

Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase 3 and is a therapeutic target.

Jun Yu, M. Go, N. Wong, 2021, Gastroenterology.

Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis.

W. Lau, N. Wong, P. Lai, 2001, Oncology research.

Frequent Integration of HBV DNA in Genomes of Hepatocellular Carcinoma Cells from Patients with Occult Infections.

N. Wong, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

A suppressor of multiple extracellular matrix-degrading proteases and cancer metastasis

N. Wong, Zuo-min Zhou, Ye Bi, 2008, Journal of cellular and molecular medicine.

Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation

Chang Xian Li, N. Wong, K. Man, 2016, Oncotarget.

Title Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation

Chang Xian Li, N. Wong, K. Man, 2016 .

Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity.

N. Wong, Yue Liu, A. M. Wong, 2022, Cancer letters.

EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.

Jun Yu, J. Sung, K. Choy, 2011, Cancer research.

Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs.

N. Wong, T. Chan, S. Ngai, 2015, Carcinogenesis.

TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk

X. Wang, N. Wong, A. Chan, 2022, Hepatology.

PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma.

N. Wong, T. Sun, N. Co, 2014, Biochemical and biophysical research communications.

Endothelial Progenitor Cell Mobilization via CXCL 10 / CXCR 3 Signaling Promotes Liver Tumor Growth

Jun Yu, N. Wong, Y. Zhai, 2013 .

Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs.

N. Wong, T. Chan, S. Ngai, 2015, Carcinogenesis.

More than a duologue: In-depth insights into epitranscriptomics and ferroptosis

N. Wong, Yujuan Dong, S. Ng, 2022, Frontiers in Cell and Developmental Biology.

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

Nathalie Wong, N. Wong, P. Lai, 2008, Gastroenterology.

Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133

N. Wong, D. Xie, X. Guan, 2014, Oncotarget.

Identification of a recurrent transforming UBR5–ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma

B. O'Sullivan, Hyungtae Kim, Jeong-Sun Seo, 2013, The Journal of pathology.

Chromosomal translocations are common in natural killer-cell lymphoma/leukemia as shown by spectral karyotyping.

N. Wong, P. Johnson, J. Chan, 2000, Human pathology.

Identification of tumor suppressive activity by irradiation microcell‐mediated chromosome transfer and involvement of alpha B‐crystallin in nasopharyngeal carcinoma

C. C. Lo, C. C. Wong, G. Robertson, 2008, International journal of cancer.

Genetic alterations in doxorubicin-resistant hepatocellular carcinoma cells: a combined study of spectral karyotyping, positional expression profiling and candidate genes.

Y. Hu, J. Squire, N. Wong, 2004, International journal of oncology.

Establishment and characterization of meningioma patient-derived organoid

N. Wong, G. Wong, A. Chan, 2021, Journal of Clinical Neuroscience.

Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.

T. T. Lau, N. Wong, S. Cheng, 2003, Oncology reports.

Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2

P. Asthana, Jian-Piao Cai, N. Wong, 2022, Nature communications.

Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy?

N. Wong, W. Poon, P. Johnston, 2020, Journal of Clinical Neuroscience.

MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.

N. Wong, K. To, A. K. Ching, 2012, Carcinogenesis.

Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.

W. Yeo, N. Wong, P. Lai, 2011, International journal of oncology.

Dependent Hepatocarcinogenesis −-Catenin β Promotes EZH 2-Mediated Concordant Repression of Wnt Antagonists

Jun Yu, K. Choy, Y. Kondo, 2011 .

Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis

K. Choy, N. Wong, P. Lai, 2010, The Journal of pathology.

Serum total glycosylation profiling for non-invasive diagnosis of liver cirrhosis in people with chronic hepatitis B.

J. Sung, T. Poon, N. Wong, 2009, Hong Kong medical journal = Xianggang yi xue za zhi.

Generation of hybrid cell lines with endothelial potential from spontaneous fusion of adult bone marrow cells with embryonic fibroblast feeder

M. Salto‐Tellez, M. Teh, S. Lim, 2004, In Vitro Cellular & Developmental Biology - Animal.

miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.

I. Ng, K. Chan, N. Wong, 2010, Cell stem cell.

Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma.

W. Lau, N. Wong, P. Lai, 2001, The American journal of pathology.

Short Communication Hypomethylation of Chromosome 1 Heterochromatin DNA Correlates with q-Arm Copy Gain in Human Hepatocellular Carcinoma

W. Lau, N. Wong, P. Johnson, 2001 .

Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.

Xiaofan Ding, Nathalie Wong, Hui Chen, 2019, Gastroenterology.

Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma

Nathalie Wong, N. Wong, Priscilla T. Y. Law, 2011, Journal of gastroenterology and hepatology.

MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling

K. Choy, N. Wong, P. Lai, 2010, Clinical Cancer Research.

Genetic alterations of lung adenocarcinoma in relation to smoking and ethnicity.

Gary Tse, Nathalie Wong, Ming-Sound Tsao, 2003, Lung cancer.

Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.

N. Wong, P. Lai, P. Johnson, 1999, The American journal of pathology.

ViralFusionSeq: accurately discover viral integration events and reconstruct fusion transcripts at single-base resolution

Ting-Fung Chan, Raymond Wan, Jing-Woei Li, 2013, Bioinform..

Spectral karyotyping indicates complex rearrangements in lung adenocarcinoma of nonsmokers.

T. Mok, N. Wong, S. Sy, 2004, Cancer genetics and cytogenetics.

Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung.

T. Mok, N. Wong, G. Tse, 2004, European journal of cancer.

Correlative Analysis of DNA Methyltransferase Expression and Promoter Hypermethylation of Tumor Suppressor Genes in Hepatocellular Carcinoma.

N. Wong, P. Lai, K. To, 2006, Cancer genomics & proteomics.

Serum of Liver Cancer Patients Methylation in the Plasma and p 16 Detection of Aberrant Updated Version

N. Wong, Y. Lo, Jun Zhang, 1998 .

Advances in Brief Detection of Aberrant p 16 Methylation in the Plasma and Serum of Liver Cancer Patients 1

W. Lau, N. Wong, P. Johnson, 1998 .

Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo

S. Cheung, S. Fan, K. Choy, 2014, Cancer Cell International.

Overexpression of ZFX confers self‐renewal and chemoresistance properties in hepatocellular carcinoma

N. Wong, P. Lai, K. Lai, 2014, International journal of cancer.

Title Overexpression of ZFX confers self-renewal andchemoresistance properties in hepatocellular carcinoma

N. Wong, P. Lai, K. Lai, 2014 .

Organoids in Lung Cancer Management

N. Wong, A. M. Wong, C. Ng, 2021, Frontiers in Surgery.

Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation

A. Hui, S. Leung, N. Wong, 1999, International journal of cancer.

Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming

Liangliang Xu, Wei Kang, Dae-Yeul Yu, 2019, Nature Communications.

Long‐Read RNA Sequencing Identifies Alternative Splice Variants in Hepatocellular Carcinoma and Tumor‐Specific Isoforms

Feng Gao, Xin Wang, Nathalie Wong, 2019, Hepatology.

GEF‐H1 over‐expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling

N. Wong, P. Lai, K. Lai, 2012, The Journal of pathology.

Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.

J. Squire, N. Wong, P. Lai, 2007, Cancer letters.

Polyploidization increases the sensitivity to DNA‐damaging agents in mammalian cells

N. Wong, P. B. Lai, P. Hau, 2006, FEBS letters.

A comparability study of immunohistochemical assays for PD-L1 expression in hepatocellular carcinoma

N. Wong, P. Lai, Lei Shi, 2019, Modern Pathology.

Frequent loss of chromosome 3p and hypermethylation of RASSF1A in cholangiocarcinoma.

N. Wong, P. B. Lai, P. Johnson, 2002, Journal of hepatology.

Profiling genomic copy number changes in retinoblastoma beyond loss of RB1

T. Corson, B. Gallie, J. Squire, 2007, Genes, chromosomes & cancer.

Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression.

N. Wong, P. Johnson, P. Lai, 2003, Journal of hepatology.

Identification of Four Distinct Regions of Allelic Imbalances on Chromosome 1 by the Combined Comparative Genomic Hybridization and Microsatellite Analysis on Hepatocellular Carcinoma

W. Lau, N. Wong, P. B. Lai, 2002, Modern Pathology.

FGF18–FGFR2 signaling triggers the activation of c-Jun–YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential

Jun Yu, Feng Wu, N. Wong, 2020, Oncogene.

Genetic imbalances in pT2 breast cancers of southern Chinese women.

N. Wong, C. Pang, P. Johnson, 2001, Cancer genetics and cytogenetics.

Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.

Nathalie Wong, N. Wong, M. He, 2015, Cancer letters.

Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.

T. Mok, S. Leung, N. Wong, 2000, Human pathology.

Karyotypic imbalances and differential gene expressions in the acquired doxorubicin resistance of hepatocellular carcinoma cells

J. Squire, N. Wong, Monique Albert, 2005, Laboratory Investigation.

Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.

Jun Yu, Juan Chen, N. Wong, 2011, Cancer research.

Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial‐to‐mesenchymal transition

N. Wong, P. Lai, A. K. Ching, 2011, Hepatology.

Detection of chromosome over- and underrepresentations in hyperdiploid acute lymphoblastic leukemia by comparative genomic hybridization.

C. Niu, N. Wong, P. Johnson, 1998, Cancer genetics and cytogenetics.

The NGS WikiBook: a dynamic collaborative online training effort with long-term sustainability

Dan M. Bolser, Maria Victoria Schneider, Daniel R. Zerbino, 2013, Briefings Bioinform..

Obesity, insulin resistance, NASH and hepatocellular carcinoma.

Jun Yu, N. Wong, Xiang Zhang, 2013, Seminars in cancer biology.

Comparison of protein expression patterns between hepatocellular carcinoma cell lines and a hepatoblastoma cell line

J. Sung, T. Poon, N. Wong, 2004, Clinical Proteomics.

TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance

Nathalie Wong, W. Yeo, N. Wong, 2009, International journal of cancer.

Unique molecular characteristics of NAFLD-associated liver cancer accentuate β-catenin/TNFRSF19-mediated immune evasion.

M. Kahn, N. Wong, P. B. Lai, 2022, Journal of hepatology.

Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.

W. Yeo, N. Wong, P. B. Lai, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Consistent chromosome 10 rearrangements in four newly established human hepatocellular carcinoma cell lines

W. Lau, N. Wong, P. Lai, 2002, Genes, chromosomes & cancer.

A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping

N. Wong, P. Lai, E. Pang, 2000, Hepatology.

Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.

N. Wong, P. Lai, K. Chan, 2008, Cancer research.

Phosphorylation of Caldesmon by PFTAIRE1 kinase promotes actin binding and formation of stress fibers

N. Wong, A. K. Ching, W. K. Leung, 2011, Molecular and Cellular Biochemistry.

Identification of PFTAIRE protein kinase 1, a novel cell division cycle‐2 related gene, in the motile phenotype of hepatocellular carcinoma cells

J. Squire, N. Wong, P. Lai, 2007, Hepatology.

Genomic aberrations in human hepatocellular carcinomas of differing etiologies.

N. Wong, P. Lai, Y. Hayashi, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.

Jun Yu, T. Yau, F. Chan, 2014, Gastroenterology.

A comprehensive karyotypic analysis on a newly developed hepatocellular carcinoma cell line, HKCI-1, by spectral karyotyping and comparative genomic hybridization.

N. Wong, P. Lai, P. Johnson, 2000, Cancer genetics and cytogenetics.

Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinoma

J. Squire, N. Wong, Monique Albert, 2005, International journal of cancer.

Recurrent chromosomal rearrangements involving breakpoints 3p21 and 19q13 in Chinese IgD multiple myeloma detected by G-banding and multicolor spectral karyotyping: a review of IgD karyotype literature.

N. Wong, M. Ng, K. Lo, 2001, Human pathology.

SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis

Jun Yu, N. Wong, K. To, 2017, Oncogene.

Regional over-representations on chromosomes 1q, 3q and 7q in the progression of hepatitis B virus-related hepatocellular carcinoma

N. Wong, P. Johnson, P. Lai, 2005, Modern Pathology.

Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition

S. Fan, N. Wong, R. Poon, 2011, PloS one.

Personalized therapy for hepatocellular carcinoma: Where are we now?

N. Wong, S. Chan, A. M. Wong, 2016, Cancer treatment reviews.

Experimental verification of microRNA targets is essential, prediction alone is insufficient.

Ting-Fung Chan, Hao Qin, Nathalie Wong, 2013, Carcinogenesis.

Stratification of Digestive Cancers with Different Pathological Features and Survival Outcomes by MicroRNA Expression

Jun Yu, S. Wong, W. Wu, 2016, Scientific Reports.

Octamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells

S. Cheung, K. Chan, N. Wong, 2016, Hepatology.

Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy.

T. Poon, N. Wong, P. Lai, 2008, Asian journal of surgery.

Small cell variant of Ki-1 lymphoma associated with myelofibrosis and a novel constitutional chromosomal translocation t(3;4) (q13;q12).

W. Yeo, N. Wong, P. Johnson, 1996, Journal of clinical pathology.

TUBB4B is a novel therapeutic target in non‐alcoholic fatty liver disease‐associated hepatocellular carcinoma

Lixia Xu, N. Wong, Jun Yu, 2023, The Journal of pathology.

Development of CD44E/s dual-targeting DNA aptamer as nanoprobe to deliver treatment in hepatocellular carcinoma

C. H. J. Choi, N. Wong, M. He, 2022, Nanotheranostics.

NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway

Jun Yu, Feng Wu, N. Wong, 2021, Oncogene.

Manipulation of the Nanoscale Presentation of Integrin Ligand Produces Cancer Cells with Enhanced Stemness and Robust Tumorigenicity.

L. Bian, Ch Lai, N. Wong, 2021, Nano letters.

Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping.

A. Hui, S. Leung, N. Wong, 2003, Cancer genetics and cytogenetics.

Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.

G. Pan, N. Wong, T. Zeng, 2015, Gastroenterology.

Transforming growth factor‐β–induced long noncoding RNA promotes liver cancer metastasis via RNA–RNA crosstalk

N. Wong, T. Sun, 2015, Hepatology.

Molecular and Cellular Pathobiology Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth

Jun Yu, Juan Chen, N. Wong, 2011 .

Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.

N. Wong, Jun Yu, Fenfen Ji, 2023, Journal of hepatology.

Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study.

Nathalie Wong, Terence C W Poon, J. Sung, 2005, Clinical chemistry.

High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis.

J. Sung, N. Wong, T. C. Poon, 2007, Clinical chemistry.

T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity.

J. Thiery, N. Wong, Wenjing Guo, 2023, Cell reports.

Transcriptional profiling identifies gene expression changes associated with IFN-alpha tolerance in hepatitis C-related hepatocellular carcinoma cells.

J. Squire, N. Wong, Monique Albert, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Sinonasal angiosarcoma with marrow involvement at presentation mimicking malignant lymphoma: cytogenetic analysis using multiple techniques.

N. Wong, Y. Kwong, J. Chan, 2001, Cancer genetics and cytogenetics.

Genomic landscape of lymphoepithelioma‐like hepatocellular carcinoma

N. Wong, A. Chan, C. Chong, 2019, The Journal of pathology.

Title Proline-rich tyrosine kinase 2 ( Pyk 2 ) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition

S. Fan, N. Wong, R. Poon, 2011 .

METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy

N. Wong, K. Man, Jun Yu, 2023, Cell reports. Medicine.

Clonal relationship of tumor nodules in hepatocellular carcinoma: a hierarchical clustering analysis of comparative genomic hybridization data.

N. Wong, P. Lai, K. To, 2005, Human pathology.

Arrest 2 Hepatocellular Carcinoma Induces G in ATF 5 Re-Expression of Transcription Factor

N. Wong, P. Lai, K. Chan, 2008 .